Back to results
US 12,691,098 B2Granted
Compositions of matter and pharmaceutical compositions
AssigneeAtai Therapeutics, Inc.
InventorsChristopher G. Witowski, Jacqueline L. Salm
Life of this patent
Estimating the term…
Abstract
Pharmaceutical formulations of novel indole compounds and psilocybin analogs are manufactured, provided in novel oral, transdermal, and nasal pharmaceutical compositions for use to treat neurological, mood or abuse diseases and disorders.
Claims22
A method of treating depression in a subject in need thereof, the method comprising mucosally administering to the subject:
- a therapeutically effective amount of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) or a pharmaceutically acceptable salt thereof,
- wherein the mucosal administration provides absorption of the 5-MeO-DMT into the blood of the subject after administration.
Dependencies are inferred from the claim text.